Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
from Journal of Hepatology
Antiviral therapy against hepatitis C (HCV) infection has proved to be safe and efficacious in patients with cirrhosis awaiting liver transplantation (LT). However, the information regarding the clinical impact of viral eradication on the waiting list is still limited. The aim of the study was to investigate the probability of delisting in patients who underwent antiviral therapy and the clinical outcomes delisted patients.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063